Christoph Aberle

Christoph Aberle

Auto-generated profile, based on publicly available information

Christoph Aberle

Department Theragnostik, Fachstelle Strahlenschutz, Universitätsspital Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in European Radiology
Verified
Journal Article
Closed access
PDF file
CAChristoph Aberle
Christoph Aberle
NRNick Ryckx
Nick Ryckx
RTReto Treier
Reto Treier
SSSebastian Schindera
Sebastian Schindera

1 October 2013 in Journal of Instrumentation
Verified
Journal Article
Open access
PDF file
CAC Aberle
C Aberle
JLJ J Li
J J Li
SWS Weiss
S Weiss
LWL Winslow
L Winslow
Semiconductor nanoparticles (quantum dots) were studied in the context of liquid scintillator development for upcoming neutrino experiments. The unique optical and chemical properties of quantum dots are particularly promising for the use in neutrinoless double-beta decay experiments. Liquid scintillators for large scale neutrino detectors have to meet specific requirements which are reviewed, highlighting the peculiarities of quantum-dot-doping. In this paper, we report results on laboratory-scale measurements of the attenuation length and the fluorescence properties of three commercial quantum dot samples. The results include absorbance and emission stability measurements, improvement in transparency due to filtering of the quantum dot samples, precipitation tests to isolate the quantum dots from solution and energy transfer studies with quantum dots and the fluorophore PPO.

16 May 2024 in Journal of Radiological Protection
Verified
Journal Article
Open access
LDLaura Dupont
Laura Dupont
CAChristoph Aberle
Christoph Aberle
DBDiomidis Botsikas
Diomidis Botsikas
MIMichael Ith
Michael Ith
TLThiago Viana Miranda Lima
Thiago Viana Miranda Lima
MMMarta Sans Merce
Marta Sans Merce
The aim of this study is to propose diagnostic reference levels (DRLs) values for mammography in Switzerland. For the data collection, a survey was conducted among a sufficient number of centres, including five University hospitals, several cantonal hospitals, and large private clinics, covering all linguistic regions of Switzerland to be representative of the clinical practice. The data gathered contained the mean glandular dose (MGD), the compressed breast thickness (CBT), the mammography model and the examination parameters for each acquisition. The data collected was sorted into the following categories: 2D or digital breast tomosynthesis (DBT) examination, craniocaudal (CC) or mediolateral oblique (MLO) projection, and eight categories of CBT ranging from 20 mm to 100 mm in 10 mm intervals. A total of 24 762 acquisitions were gathered in 31 centres on 36 mammography units from six manufacturers. The analysis showed that the data reflects the practice in Switzerland. The results revealed that the MGD is larger for DBT than for 2D acquisitions for the same CBT. From 20–30 mm to 90–100 mm of CBT, the 75th percentile of the MGD values obtained increased from 0.81 mGy to 2.55 mGy for 2D CC acquisitions, from 0.83 mGy to 2.96 mGy for 2D MLO acquisitions, from 1.22 mGy to 3.66 mGy for DBT CC acquisitions and from 1.33 mGy to 4.04 mGy for DBT MLO acquisitions. The results of the survey allow us to propose Swiss DRLs for mammography according to the examination type (2D/DBT), projection (CC/MLO) and CBT. The proposed values are very satisfactory in comparison with other studies.

31 May 2023 in Clinical Neuroradiology
Verified
Journal Article
Open access
PDF file
MEManina M. Etter
Manina M. Etter
KNKieu Anh Thi Nguyen
Kieu Anh Thi Nguyen
ABAlex Brehm
Alex Brehm
CAChristoph Aberle
Christoph Aberle
ITIoannis Tsogkas
Ioannis Tsogkas
Marios-Nikos PsychogiosMarios-Nikos Psychogios
Marios-Nikos Psychogios
Purpose: Hemorrhagic stroke, particularly occurring from ruptured cerebrovascular malformations, is responsible for 5–12% of all maternal deaths during pregnancy and the puerperium. Whether endovascular treatment is feasible and safe for both the mother and the fetus, is still a matter of debate. The main objective of this case series and systematic review was to share our multi-institutional experience and to assess the feasibility and safety of endovascular treatment during pregnancy, as well as the corresponding maternal and fetal outcomes based on currently available evidence. Methods: We report a case series of 12 pregnant women presenting with hemorrhagic stroke from ruptured cerebrovascular arteriovenous malformations or aneurysms who underwent endovascular treatment prior to delivery. A systematic literature review of pregnant patients with endovascular treated cerebrovascular malformations, published between 1995 and 2022, was performed. Clinical patient information, detailed treatment strategies, maternal and fetal outcomes as well as information on the delivery were collected and assessed. Results: In most patients the course was uneventful and an excellent outcome without significant neurological deficits (mRS ≤ 1) was achieved. Furthermore, the maternal outcome was not worse compared to the general population who underwent endovascular treatment of ruptured vascular brain lesions. Also, in most cases a healthy fetus was born. Conclusion: Endovascular treatment of ruptured cerebrovascular malformations during pregnancy is safe and feasible regarding both aspects, the maternal and fetal outcomes. Still, a stronger knowledge base is needed to correctly approach future cases of intracranial hemorrhage in the pregnant population.

10 May 2016 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
CAChristoph Aberle
Christoph Aberle
RKRalf-Peter Kapsch
Ralf-Peter Kapsch
A commercial computed radiography (CR) system was studied as an option for quantitative dosimetry quality assurance of external radiotherapy beams. Following the examination of influencing quantities, practical measurement procedures are discussed. Corrections were derived for image fading, an observed long-term response drift and the image length scale, which was found to be off by up to 2–3%. It is known that energy dependence is important for CR measurements. Therefore, signal-to-dose calibration curves and the energy dependence of the response were studied extensively using multiple photon and electron beam qualities. Doses which yield the same signal vary by up to tens of percent for different beam qualities. Results on the directional response of the plates are presented. It was found that rotations of up to 30° to 40° relative to perpendicular irradiation yield no significant change in response. Finally, the homogeneity of the response over the measurement region was studied for electrons and photons and a correction method is described. In summary, relative dose measurements with uncertainties of a few percent are feasible in regions of constant beam energy.

30 June 2026 in Physica Medica
Verified
Journal Article
Open access
ESEleni Theano Samara
Eleni Theano Samara
JEJonas Ekeberg
Jonas Ekeberg
GPGustavo S.P. Pamplona
Gustavo S.P. Pamplona
ASAnja Stüssi
Anja Stüssi
RTReto Treier
Reto Treier
ASArdan M. Saguner
Ardan M. Saguner
Diagnostic reference levels (DRLs) have been proven to be a useful tool for optimizing patient radiation exposure. National DRLs (NDRLs) are defined based on data from a representative sample of the healthcare facilities in a particular country. This project presents the survey to update the NDRLs for cardiac interventional procedures in Switzerland. Healthcare facilities performing cardiac procedures in Switzerland were asked to provide radiation dose data for adult cardiac interventional procedures performed over the course of one year. The dataset included the procedure name and the corresponding air kerma area product, air kerma at the reference point, fluoroscopy time and number of cine acquisitions. Thirty-five healthcare facilities (95% of the total) provided data. The procedures were grouped into 11 electrophysiology procedures, 4 cardiac catheterization procedures, and 3 structural heart procedures. For each healthcare facility and radiation quantity, the median values were calculated. Updated NDRLs were determined as the 75th percentile of the distribution of these median values. For example, the updated NDRL for air kerma area product was set at 24 Gy∙cm2 for coronary angiography and at 2 Gy∙cm2 for pacemaker implantation, reflecting a substantial reduction from the prior NDRL values of 50 and 30 Gy∙cm2, respectively. These new NDRL values are substantially lower than the previous ones, highlighting the importance of conducting regular updates to accommodate continuous patient dose optimization of and technological advancements.